ACRVNasdaqPharmaceutical PreparationsFiscal year ends December 31
Acrivon Therapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$1.69+0.05 (+3.05%)
Close on Oct 19, 2026
- Market cap
- $70.71M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
49.9%
21M of 43M shares
Institutional holders
46
6 new, 4 sold out
Net institutional buying
5M
In Q2 2026
Insider trades, 12 months
3 buys · 9 sales
Net bought $74.68K
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Wiaczeslaw Smolokowski | 3,848,632 | – | 13G (passive) amendment | Jun 30, 2024 |
| Perceptive Advisors LLC | 3,104,139 | 9.90% | 13G (passive) amendment | Apr 29, 2025 |
| Sands Capital Life Sciences Pulse Fund II, L.P. | 2,289,271 | 5.30% | 13G (passive) amendment | Jun 30, 2026 |
| Sands Capital Alternatives, LLC | 2,122,605 | 6.80% | 13G (passive) amendment | Jun 30, 2025 |
| Kenneth Griffin | 1,721,867 | 5.50% | 13G (passive) | Nov 14, 2025 |
| Sands Capital Ventures, LLC | 1,652,605 | 7.40% | 13G (passive) amendment | Dec 31, 2023 |
| Rajeev Shah | 12,284,906 | 28.80% | 13D (active) amendment | Apr 22, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of ACRV | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Ra Capital Management, L.P. | 12,229,396 | 28.54% | $21.77M | +3,888,888 | 0.19% |
| Sands Capital Ventures, LLC | 2,289,271 | 5.34% | $4.07M | +166,666 | 0.66% |
| Acadian Asset Management LLC | 1,165,119 | 2.72% | $2.07K | +319,146 | 0.00% |
| Vanguard Capital Management LLC | 952,008 | 2.22% | $1.69M | +229,973 | 0.00% |
| Wellington Management Group Llp | 888,130 | 2.07% | $1.58M | – | 0.00% |
| Renaissance Technologies LLC | 758,863 | 1.77% | $1.35M | +423 | 0.00% |
| Two Sigma Investments, LP | 641,498 | 1.50% | $1.14M | +252,103 | 0.00% |
| Marshall Wace, Llp | 531,856 | 1.24% | $946.70K | −28,580 | 0.00% |
| Bridgeway Capital Management, LLC | 378,900 | 0.88% | $674.44K | +220,000 | 0.01% |
| Geode Capital Management, LLC | 265,241 | 0.62% | $472.27K | +28,850 | 0.00% |
| BlackRock, Inc. | 239,112 | 0.56% | $425.62K | +30,173 | 0.00% |
| Gsa Capital Partners Llp | 200,415 | 0.47% | $357 | +13,699 | 0.02% |
| Vanguard Fiduciary Trust Co | 184,128 | 0.43% | $327.75K | +76,599 | 0.00% |
| XTX Topco Ltd | 178,239 | 0.42% | $317.27K | +111,357 | 0.00% |
| Jane Street Group, LLC | 74,648 | 0.17% | $132.87K | −165,043 | 0.00% |
| Northern Trust Corp | 67,202 | 0.16% | $119.62K | +18,300 | 0.00% |
| State Street Corp | 67,145 | 0.16% | $119.52K | – | 0.00% |
| UBS Group AG | 43,850 | 0.10% | $78.05K | +9,216 | 0.00% |
| Citadel Advisors LLC | 41,276 | 0.10% | $73.47K | New | 0.00% |
| Dimensional Fund Advisors LP | 29,332 | 0.07% | $52.21K | +10,968 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 46 | 21M | 49.9% | 6 / 21 | 9 / 4 | 5M | 0M |
| Q1 2026 | 44 | 16M | 37.9% | 10 / 11 | 11 / 13 | 2M | 3M |
| Q4 2025 | 48 | 19M | 43.4% | 8 / 16 | 10 / 8 | 2M | 1M |
| Q3 2025 | 48 | 18M | 40.9% | 6 / 11 | 19 / 11 | 1M | 2M |
| Q2 2025 | 53 | 18M | 41.5% | 15 / 11 | 17 / 25 | 2M | 7M |
| Q1 2025 | 63 | 23M | 52.6% | 8 / 17 | 22 / 7 | 0M | 1M |
| Q4 2024 | 63 | 23M | 54.3% | 13 / 18 | 15 / 5 | 1M | 1M |
| Q3 2024 | 55 | 23M | 54.0% | 8 / 17 | 14 / 7 | 2M | 1M |
| Q2 2024 | 55 | 23M | 54.8% | 12 / 24 | 7 / 5 | 8M | 0M |
| Q1 2024 | 48 | 15M | 35.7% | 12 / 15 | 8 / 6 | 1M | 1M |
| Q4 2023 | 42 | 15M | 35.9% | 3 / 16 | 9 / 4 | 0M | 0M |
| Q3 2023 | 43 | 15M | 35.2% | 4 / 15 | 12 / 1 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of ACRV | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 545,541 | 1.27% | $971.06K | 0.00% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 389,575 | 0.91% | $693.44K | 0.00% | Jun 30, 2026 |
| Ultra-Small Company Fund | 316,000 | 0.74% | $562.48K | 0.57% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 111,335 | 0.26% | $178.14K | 0.00% | May 31, 2026 |
| iShares Micro-Cap ETF | 73,869 | 0.17% | $131.49K | 0.01% | Jun 30, 2026 |
| Ultra-Small Company Market Fund | 58,000 | 0.14% | $103.24K | 0.07% | Jun 30, 2026 |
| Fidelity Series Total Market Index Fund | 27,696 | 0.06% | $44.31K | 0.00% | May 31, 2026 |
| Fidelity Total Market Index Fund | 24,809 | 0.06% | $39.69K | 0.00% | May 31, 2026 |
| Fidelity Nasdaq Composite Index Fund | 18,053 | 0.04% | $28.88K | 0.00% | May 31, 2026 |
| Vanguard Balanced Index Fund | 16,892 | 0.04% | $30.07K | 0.00% | Jun 30, 2026 |
| 1290 VT Micro Cap Portfolio | 4,941 | 0.01% | $8.79K | 0.00% | Jun 30, 2026 |
| Blackstone Alternative Multi-Strategy Fund | 2,500 | 0.01% | $4.45K | 0.00% | Jun 30, 2026 |
| Total Stock Market Index Trust | 937 | 0.00% | $1.67K | 0.00% | Jun 30, 2026 |
| Knights of Columbus U.S. ALL CAP INDEX FUND | 115 | 0.00% | $173 | 0.00% | Jul 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Kristina Masson | EVP - Business Operations, Director | 2,629,947 | 6.14% | Aug 27, 2026 |
| Peter Blume-Jensen | President and CEO, Director | 2,615,911 | 6.10% | Aug 27, 2026 |
| Michaela Levin | Chief Business Officer | 30,000 | 0.07% | Sep 2, 2026 |
| Eric Devroe | Chief Operating Officer | 146,349 | 0.34% | Aug 20, 2026 |
| Katharine Peterson | Chief Accounting Officer | 18,033 | 0.04% | Aug 20, 2026 |
| Erick Gamelin | Chief Development Officer | 52,592 | 0.12% | Aug 20, 2026 |
| Mary Miller | Chief Legal Officer | 82,009 | 0.19% | Aug 20, 2026 |
| Adam D. Levy | Chief Financial Officer | 66,008 | 0.15% | Aug 6, 2026 |
| Mansoor Raza Mirza | Chief Medical Officer | 38,817 | 0.09% | May 20, 2026 |
| Rasmus Holm-Jorgensen | Chief Financial Officer | 26,088 | 0.06% | Mar 4, 2025 |
| Jean-Marie Cuillerot | Chief Medical Officer | – | – | Mar 4, 2025 |
| Santhosh Palani | Director | 9,366 | 0.02% | Jun 22, 2026 |
| Rajeev M. Shah | Director, 10% owner | – | – | Jun 22, 2026 |
| Peter Kolchinsky | Director, 10% owner | – | – | Jun 22, 2026 |
| Ra Capital Management, L.P. | Director, 10% owner | – | – | Jun 22, 2026 |
| RA Capital Nexus Fund II, L.P. | Director | 9,366 | 0.02% | Jun 22, 2026 |
| Charles M. Baum | Director | 9,366 | 0.02% | Jun 22, 2026 |
| Derek DiRocco | Director | 9,366 | 0.02% | Jun 22, 2026 |
| Capital Healthcare Fund LP RA | Director, 10% owner | 7,914,206 | 18.47% | Jun 22, 2026 |
| Sharon Shacham | Director | 9,366 | 0.02% | Jun 22, 2026 |
| Michael John Tomsicek | Director | 9,366 | 0.02% | Jun 22, 2026 |
| Ivana Magovcevic-Liebisch | Director | 9,366 | 0.02% | Jun 22, 2026 |
| Joseph Edelman | 10% owner | 3,007,858 | 7.02% | May 1, 2025 |
| Advisors Llc Perceptive | 10% owner | 3,104,139 | 7.24% | May 1, 2025 |
| Life Sciences Master Fund Ltd Perceptive | 10% owner | 5,360,858 | 12.51% | May 1, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Michaela Levin Chief Business Officer | Aug 31, 2026 | Award | +30,000 | – | – | 30,000 |
| Peter Blume-Jensen President and CEO, Director | Aug 25, 2026 | Sale | −14,036 | $2.21 | $31.02K | 2,230,052 |
| Erick Gamelin Chief Development Officer | Aug 18, 2026 | Sale | −400 | $2.01 | $804 | 52,592 |
| Mary Miller Chief Legal Officer | Aug 18, 2026 | Sale | −185 | $2.01 | $372 | 82,009 |
| Kristina Masson EVP - Business Operations, Director | Aug 18, 2026 | Sale | −484 | $2.01 | $973 | 385,859 |
| Kristina Masson EVP - Business Operations, Director | Aug 18, 2026 | Sale | −1,229 | $2.01 | $2.47K | 2,244,088 |
| Katharine Peterson Chief Accounting Officer | Aug 18, 2026 | Sale | −101 | $2.01 | $203 | 18,033 |
| Eric Devroe Chief Operating Officer | Aug 18, 2026 | Sale | −604 | $2.01 | $1.21K | 146,349 |
| Adam D. Levy Chief Financial Officer | Aug 4, 2026 | Sale | −1,142 | $1.57 | $1.79K | 66,008 |
| Mary Miller Chief Legal Officer | Jul 21, 2026 | Sale | −573 | $1.76 | $1.01K | 82,194 |
| Kristina Masson EVP - Business Operations, Director | May 21, 2026 | Tax withholding | −13,729 | $1.79 | $24.57K | 2,245,317 |
| Peter Blume-Jensen President and CEO, Director | May 18, 2026 | Award | +180,095 | – | – | 2,259,046 |
| Peter Blume-Jensen President and CEO, Director | May 18, 2026 | Award | +72,706 | – | – | 386,343 |
| Katharine Peterson Chief Accounting Officer | May 18, 2026 | Award | +14,227 | – | – | 18,134 |
| Erick Gamelin Chief Development Officer | May 18, 2026 | Award | +38,584 | – | – | 52,992 |
| Derek DiRocco Director | May 18, 2026 | Award | +9,366 | – | – | 9,366 |
| Michael John Tomsicek Director | May 18, 2026 | Award | +9,366 | – | – | 9,366 |
| Mary Miller Chief Legal Officer | May 18, 2026 | Award | +49,830 | – | – | 82,767 |
| Ivana Magovcevic-Liebisch Director | May 18, 2026 | Award | +9,366 | – | – | 9,366 |
| Eric Devroe Chief Operating Officer | May 18, 2026 | Award | +72,981 | – | – | 146,953 |
| Adam D. Levy Chief Financial Officer | May 18, 2026 | Award | +46,167 | – | – | 67,150 |
| Santhosh Palani Director | May 18, 2026 | Award | +9,366 | – | – | 9,366 |
| RA Capital Nexus Fund II, L.P. Director | May 18, 2026 | Award | +9,366 | – | – | 9,366 |
| Mansoor Raza Mirza Chief Medical Officer | May 18, 2026 | Award | +38,817 | – | – | 38,817 |
| Sharon Shacham Director | May 18, 2026 | Award | +9,366 | – | – | 9,366 |
| Charles M. Baum Director | May 18, 2026 | Award | +9,366 | – | – | 9,366 |
| Eric Devroe Chief Operating Officer | May 14, 2026 | Tax withholding | −613 | $1.92 | $1.18K | 73,972 |
| Erick Gamelin Chief Development Officer | May 14, 2026 | Tax withholding | −404 | $1.92 | $776 | 14,408 |
| Mary Miller Chief Legal Officer | May 14, 2026 | Tax withholding | −184 | $1.92 | $353 | 32,937 |
| Katharine Peterson Chief Accounting Officer | May 14, 2026 | Tax withholding | −99 | $1.92 | $190 | 3,907 |
| Peter Blume-Jensen President and CEO, Director | May 14, 2026 | Tax withholding | −490 | $1.92 | $941 | 313,637 |
| Peter Blume-Jensen President and CEO, Director | May 14, 2026 | Tax withholding | −1,253 | $1.92 | $2.41K | 2,078,951 |
| RA Capital Nexus Fund II, L.P. Director | Apr 22, 2026 | Award | +3,888,888 | $1.80 | $7.00M | 11,803,094 |
| Mary Miller Chief Legal Officer | Apr 17, 2026 | Tax withholding | −558 | $1.78 | $993 | 33,121 |
| Peter Blume-Jensen President and CEO, Director | Feb 21, 2026 | Tax withholding | −14,265 | $1.53 | $21.83K | 2,080,204 |
| Erick Gamelin Chief Development Officer | Feb 14, 2026 | Tax withholding | −471 | $1.63 | $768 | 14,812 |
| Katharine Peterson Chief Accounting Officer | Feb 14, 2026 | Tax withholding | −116 | $1.63 | $189 | 4,006 |
| Peter Blume-Jensen President and CEO, Director | Feb 14, 2026 | Tax withholding | −1,302 | $1.63 | $2.12K | 2,094,469 |
| Peter Blume-Jensen President and CEO, Director | Feb 14, 2026 | Tax withholding | −579 | $1.63 | $944 | 314,127 |
| Eric Devroe Chief Operating Officer | Feb 14, 2026 | Tax withholding | −723 | $1.63 | $1.18K | 74,585 |
| Mary Miller Chief Legal Officer | Feb 14, 2026 | Tax withholding | −217 | $1.63 | $354 | 33,679 |
| Mary Miller Chief Legal Officer | Jan 17, 2026 | Tax withholding | −659 | $1.98 | $1.30K | 33,896 |
| Peter Blume-Jensen President and CEO, Director | Jan 14, 2026 | Buy | +49,000 | $1.68 | $82.32K | 2,095,771 |
| Adam D. Levy Chief Financial Officer | Jan 14, 2026 | Buy | +8,832 | $1.70 | $15.01K | 20,983 |
| Eric Devroe Chief Operating Officer | Jan 13, 2026 | Buy | +10,000 | $1.72 | $17.20K | 75,308 |
| Kristina Masson EVP - Business Operations, Director | Nov 21, 2025 | Tax withholding | −19,904 | $2.30 | $45.78K | 2,046,771 |
| Katharine Peterson Chief Accounting Officer | Nov 14, 2025 | Tax withholding | −99 | $2.24 | $222 | 4,122 |
| Kristina Masson EVP - Business Operations, Director | Nov 14, 2025 | Tax withholding | −59,765 | $2.24 | $133.87K | 2,066,675 |
| Kristina Masson EVP - Business Operations, Director | Nov 14, 2025 | Tax withholding | −490 | $2.24 | $1.10K | 314,706 |
| Mary Miller Chief Legal Officer | Nov 14, 2025 | Tax withholding | −184 | $2.24 | $412 | 34,555 |
| Erick Gamelin Chief Development Officer | Nov 14, 2025 | Tax withholding | −403 | $2.24 | $903 | 15,283 |
| Eric Devroe Chief Operating Officer | Nov 14, 2025 | Tax withholding | −613 | $2.24 | $1.37K | 65,308 |
| Mary Miller Chief Legal Officer | Oct 17, 2025 | Tax withholding | −558 | $1.81 | $1.01K | 34,739 |
| Mary Miller Chief Legal Officer | Oct 1, 2025 | Tax withholding | −284 | $1.81 | $514 | 35,297 |
| Kristina Masson EVP - Business Operations, Director | Aug 21, 2025 | Tax withholding | −19,905 | $1.32 | $26.27K | 2,126,440 |
| Eric Devroe Chief Operating Officer | Aug 14, 2025 | Tax withholding | −613 | $1.39 | $852 | 65,921 |
| Katharine Peterson Chief Accounting Officer | Aug 14, 2025 | Tax withholding | −99 | $1.39 | $138 | 4,221 |
| Kristina Masson EVP - Business Operations, Director | Aug 14, 2025 | Tax withholding | −59,766 | $1.39 | $83.07K | 2,146,345 |
| Kristina Masson EVP - Business Operations, Director | Aug 14, 2025 | Tax withholding | −490 | $1.39 | $681 | 315,196 |
| Erick Gamelin Chief Development Officer | Aug 14, 2025 | Tax withholding | −403 | $1.39 | $560 | 15,686 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Blume-Jensen Peter Officer, Director | Aug 25, 2026 | 14,036 | $30.60K | Aug 25, 2026 | Settlement of vested RSUs issued under an S-8 Registration Plan |
| Ltd Chione 10% Stockholder | Jun 12, 2023 | 219,259 | $2.73M | Jun 12, 2023 | conversion of shares of series A-1 preferred stock |